October 7, 2016 12:00 pm
Published by jonas
Redwood Pharmas utveckling av ögonläkemedlet RP101 använder sig av IntelliGel som drug delivery plattform. Den har nu testats i en... View Article
September 20, 2016 12:00 pm
Published by jonas
Redwood Pharma AB (publ), a company that develops pharmaceuticals within ophthalmology, announces today that Ulf Björklund has accepted the company’s... View Article
September 20, 2016 12:00 pm
Published by jonas
Redwood Pharma AB (publ), ett läkemedelsutvecklingsföretag som utvecklar nya läkemedel för behandling av ögonsjukdomar. Idag har Redwood Pharma skrivit kontrakt... View Article
September 16, 2016 12:00 pm
Published by jonas
Women make up two thirds of those suffering from Dry Eye Disease (DED). Presentations and scientific results shown at TFOS,... View Article
September 16, 2016 12:00 pm
Published by jonas
Kvinnor utgör två tredjedelar av alla som drabbats av DED (torra ögonsjukdom). Presentationerna och forskningsresultaten på TFOS-konferensen, som hölls den... View Article
August 30, 2016 12:00 pm
Published by jonas
The granting of a Japanese patent for the IntelliGel® platform opens a significant global market within ophthalmic medicines to Redwood... View Article
August 30, 2016 12:00 pm
Published by jonas
Patentet för IntelliGel®-plattformen har godkänts i Japan. Godkännandet öppnar upp en stor ögonmarknad för Redwood Pharma. Den japanska marknaden för... View Article
August 11, 2016 12:00 pm
Published by jonas
On October 20th, Redwood Pharma AB (publ.) will present at the French-Swedish Life Science Day organized by Business Sweden, the... View Article
August 11, 2016 12:00 pm
Published by jonas
Den 20 oktober kommer Redwood Pharma AB (publ) att delta och presentera bolaget på den svenska ambassaden i Paris vid... View Article
August 9, 2016 12:00 pm
Published by jonas
The 8th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance will occur from September... View Article